Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

Sawitzki B. et al, (2020), Lancet, 395, 1627 - 1639

Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation - Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation.

Mengel M. et al, (2020), Am J Transplant

Pre-transplant Management and Sensitisation in Vascularised Composite Allotransplantation: A Systematic Review

ISSA F. et al, (2020), Journal of Plastic, Reconstructive and Aesthetic Surgery

Distinct metabolic pathways mediate regulatory T cell differentiation and function.

Hashimoto H. et al, (2020), Immunol Lett, 223, 53 - 61

The ONE Study: Evaluation of Regulatory Cell Therapy in Kidney Transplantation Using a Harmonized Trial Design

HESTER J. et al, (2020), The Lancet

Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease and Regenerative Medicine.

Adigbli G. et al, (2020), Transplantation

Research Highlights

Issa F. and Cross A., (2020), Transplantation, 104, 227 - 228

The First International Transplant Science (ITS) Meeting.

Chong AS. et al, (2020), Transplantation

Research Highlights

Cross A. and Issa F., (2019), Transplantation, 103, 2453 - 2454

Development and Validation of a Peripheral Blood mRNA Assay for the Assessment of Antibody-mediated Kidney Allograft Rejection: A Multicentre, Prospective Study

Issa F., (2019), TRANSPLANTATION, 103, 1968 - 1969

DEVELOPMENT OF A METHODOLOGY FOR THE PRODUCTION OF SPECIFIC ALLOANTIGEN - REACTIVE HUMAN TREGS

Alzhrani A. et al, (2019), TRANSPLANT INTERNATIONAL, 32, 280 - 280

MODULATION OF THE IL-33/ST2 AXIS FOR REGULATORY T CELL THERAPY IN TRANSPLANTATION

Kawai K. et al, (2019), TRANSPLANT INTERNATIONAL, 32, 136 - 136

THE EFFECTS OF AN IL-21 RECEPTOR ANTAGONIST ON THE ALLOIMMUNE RESPONSE IN A HUMANIZED SKIN TRANSPLANT MOUSE MODEL

Hoogduijn M. et al, (2019), TRANSPLANT INTERNATIONAL, 32, 59 - 59

ITS finally here! The first International Transplant Science meeting jointly organized by AST, ESOT and TTS.

Chong AS. et al, (2019), Transplantation

Research Highlights

Issa F., (2019), Transplantation, 103, 1526 - 1527

Selective Hematopoietic Stem Cell Ablation Using CD117-Antibody-drug-conjugates Enables Safe and Effective Transplantation With Immunity Preservation

Issa F., (2019), TRANSPLANTATION, 103, 1526 - 1526

Three Types of Functional Regulatory T Cells Control T Cell Responses at the Human Maternal-fetal Interface

Issa F., (2019), TRANSPLANTATION, 103, 1526 - 1527

Systemic silencing of HIF hydroxylase PHD2 causes reversible immunoregulatory dysfunction

YAMAMOTO A. et al, (2019), Journal of Clinical Investigation

Systemic silencing of PHD2 causes reversible immune regulatory dysfunction.

Yamamoto A. et al, (2019), J Clin Invest, 130

A Urinary MicroRNA Panel That Is an Early Predictive Biomarker of Delayed Graft Function Following Kidney Transplantation

Issa F., (2019), TRANSPLANTATION, 103, 1070 - 1070

Load More

1
2
3
4
5
6
7

Include forthcoming?